Baku 7° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
14:02
Azerbaijani parliament ratifies agreement on customs co-op with Jordan
Milli Majlis13:52
China executes 4 leading members of northern Myanmar-based criminal gangs
Other countries13:43
Azerbaijan weather forecast for February 3
Ecology13:32
Portugal pledges €2.5B for deadly storm recovery as rains persist
Other countries13:20
Iran to take retaliatory measures against EU in coming days
Region13:16
Over 1,738 hectares cleared of mines in Azerbaijan's liberated lands in Jan.
Domestic policy13:03
Three killed as training aircraft crashes in Russia's Orsk
Region12:42
Dozens confirmed dead as extreme cold continues to grip large part of US
Other countries12:28